article thumbnail

Oral Metabolic Drug Acquired by Novo Nordisk Continues to Show Concerning Neuro Side Effects

MedCity News

Novo Nordisks monlunabant showed signs of neuropsychiatric side effects in a mid-stage diabetic kidney disease study, despite a drug design intended to favor hitting its target receptor in peripheral tissues rather than the brain. Neuro effects were also reported last year in a Phase 2 test of this pill in obesity.

article thumbnail

Side Effects are Limiting GLP-1 Drug Efficacy: How Can Personalization Offer a Solution?

MedCity News

By integrating digitization and machine learning, there is an opportunity to deliver personalized care to all patients and scale precision dosing with minimal physician involvement, maximizing the effectiveness and accessibility of these drugs. The post Side Effects are Limiting GLP-1 Drug Efficacy: How Can Personalization Offer a Solution?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UK regulators warn of ocular side effects after treatment with Sanofi's Dupixent

Fierce Pharma

UK regulators warn of ocular side effects after treatment with Sanofi's Dupixent. Wed, 11/30/2022 - 10:55.

article thumbnail

Serious Side Effect Sidelines Gene-Edited Sickle Cell Therapy from Graphite Bio

MedCity News

Graphite Bio voluntarily paused a Phase 1/2 test of its gene-edited therapy for sickle cell disease after the first patient in the study developed a serious blood complication. The setback will also delay plans to reach the clinic with another genetic medicine in its pipeline.

article thumbnail

Seeking full approval in Alzheimer's, Eisai dives into prominent Leqembi side effect

Fierce Pharma

Seeking full approval in Alzheimer's, Eisai dives into prominent Leqembi side effect fkansteiner Fri, 03/31/2023 - 11:30

article thumbnail

Uniqueness if pharma DTC

World of DTC Marketing

Pharma DTC marketing is unique, and drug marketers need to think more about the journey from awareness to requesting an Rx. The hottest pharma product is Lilly’s diabetes drug, hyped by the media as helping patients lose weight. Most of the media stories, however, leave out the possible drug side effects, which are serious.

Pharma 210
article thumbnail

Apellis flags needle problems in hunt for Syfovre side effect source

Fierce Pharma

While nothing is certain yet, Apellis may be homing in on the source of a rare but serious side effect tied to its world-first geographic atrophy drug Syfovre. While nothing is certain yet, Apellis may be homing in on the source of a rare but serious side effect tied to its world-first geographic atrophy drug Syfovre.